R3HDM2 antibody
Principal name
R3HDM2 antibody
Alternative names for R3HDM2 antibody
KIAA1002, R3H domain-containing protein 2
Ncbi ID
9606, NP_055740, NM_014925, NP_055740.3, NP_001161764.1, NM_027900, NM_001168293, NM_001168292
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB)
Background of R3HDM2 antibody
- Kit Component:
- - KN314319G1, R3hdm2 gRNA vector 1 in pCas-Guide vector
- KN314319G2, R3hdm2 gRNA vector 2 in pCas-Guide vector
- KN314319D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Lim,J., (2006) Cell 125 (4), 801-814

Immunofluorescence of purified MaxPab antibody to R3HDM2 on HeLa cell. [antibody concentration 10 ug/ml]

Western Blot analysis of R3HDM2 expression in transfected 293T cell line (H00022864-T02) by R3HDM2 MaxPab polyclonal antibody.Lane 1: KIAA1002 transfected lysate(70.07 KDa).Lane 2: Non-transfected lysate.

Human 293T; WB Suggested Anti-R3HDM2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: 293T cell lysate. R3HDM2 is supported by BioGPS gene expression data to be expressed in HEK293T.; R3HDM2 antibody - middle region (ARP55106_P050) in Human 293T cells using Western Blot
Lysates
| Catalog No. | ||
|---|---|---|
| LY414932 | R3HDM2 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC207351L2V | Lenti ORF particles, R3HDM2 (mGFP-tagged) - Human R3H domain containing 2 (R3HDM2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,130.00
|
|
| OriGene Technologies, Inc. | ||

